Insight Molecular Diagnostics Inc. (7OC0)
Munich
Closed
Oct 8, 2026
Day's Range
2.7852 wk Range
2.78Overview - 7OC0 - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
66.57M
P/E (Trailing)
‪-1.68‬
PEG Ratio
‪-0.50‬
Price / Sales (TTM)
‪54.47‬
Price / Book
‪-4.79‬
EV / EBITDA
‪-2.19‬
Profitability
Gross Margin
‪65.69%‬
Profit Margin
‪56.67%‬
Operating Margin
‪-3,815.06%‬
Return on Assets
‪-57.82%‬
Return on Equity
‪159.61%‬
Ownership
Shares Outstanding
32.62M
Float
10.40M
Held by Insiders
‪20.99%‬
Held by Institutions
‪56.42%‬
Price stats
Beta
‪1.80‬
50-Day Avg
‪2.78‬
200-Day Avg
‪2.78‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 7OC0 - Insight Molecular Diagnostics Inc.
Peers - 7OC0 - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
Profile Summary - 7OC0 - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
